GAINESVILLE, Fla., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that the U.S. Environmental Protection Agency has granted registration of the Company's patent-pending Stay Fresh® Antimicrobial Technology for use in a wide range of textile applications including apparel, interior furnishings, automotive upholstery and carpeting.
Stay Fresh is a breakthrough antimicrobial technology. What makes Stay Fresh different from other antimicrobials is its chemistry and extraordinary durability. The active ingredient is hydrogen peroxide – the ingredient that provides the gentle disinfecting and bleaching action in today's generation of color-safe, alternative bleaches. This advance is made possible by Quick-Med's development of the first commercially viable technology for bonding the active ingredient onto the textile.
Stay Fresh is the only antimicrobial technology containing hydrogen peroxide approved by EPA for antimicrobial preservation of textiles.
Stay Fresh overcomes the major shortcoming of existing technologies by providing antimicrobial effectiveness after repeated laundering. "Stay Fresh textile treatment locks the power of hydrogen peroxide into fabrics," according to J. Ladd Greeno, CEO of Quick-Med. "By incorporating this potent antimicrobial into fabrics, we bring highly effective antimicrobial activity to a wide range of textile applications where the durability after repeated laundering has been an unmet challenge. Textiles stay fresher for longer because the active agent is now held in place on the fabric."
Safe and Effective
Hydrogen peroxide is nature's own antimicrobial agent, produced by human cells to fight invasive bacteria, and naturally occurring in honey as a preservative. Consumers are familiar with hydrogen peroxide as a color-safe bleaching agent and stain fighter for laundering applications.
Hydrogen peroxide is known to be a powerful antimicrobial. It is highly effective against a wide range of microorganisms, including bacteria, mold, mildew, fungi, algae, and viruses. Very low concentrations of hydrogen peroxide also have been shown to be effective in guarding against the growth of odors from microbial causes and in resisting deterioration or staining caused by fungi, molds and mildew.
Stay Fresh – A Powerful New Entrant to the Market
Quick-Med's Stay Fresh Technology can be used by textile manufacturers to provide a new level of antimicrobial durability for laundered textiles. This is achieved at low cost without requiring alteration in production facilities. "Stay Fresh outperforms other technologies and can satisfy unfulfilled demand in markets where current products are simply not good enough," added Mr. Greeno.
This represents the first regulatory clearance for Stay Fresh. The Company also plans to seek approval from the U.S. Food and Drug Administration for use of Stay Fresh in select medical device applications.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the consumer and healthcare markets. The Company is developing advanced antimicrobial technologies for infection prevention and control. Its NIMBUS® technology is the first FDA-cleared, non-leaching antimicrobial available in a wound dressing. Its NimbuDerm™ technology is being developed as a persistent hand sanitizer and Stay Fresh® technology, the Company's latest innovation, provides highly durable antimicrobial protection for apparel and other textile applications. For more information, see: .
The Quick-Med Technologies, Inc. logo is available at
© 2011 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and Stay Fresh® are registered trademarks and NimbuDerm™ is a trademark of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at .
CONTACT: Quick-Med Technologies, Inc. J. Ladd Greeno, CEO (888) 835.2211 Ext 102 firstname.lastname@example.org Stonegate Securities, Inc. Casey Stegman (investor/media contact) (214) 987-4121 email@example.com